NCT05613608View on ClinicalTrials.gov

Alcohol Use Disorder and Cannabidiol

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 30, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Alcohol Use Disorder
Interventions
DRUG

Cannabidiol

The current study will directly test the hypothesis that a moderate dose of CBD leads to a reduction in alcohol consumption, alcohol craving, peripheral markers of inflammation, and anxiety.

DRUG

Placebo

Placebo arm.

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz, Aurora

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Colorado, Denver

OTHER